306 related articles for article (PubMed ID: 25835638)
1. Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy.
Shabani M; Naseri J; Shokri F
Expert Opin Ther Targets; 2015 Jul; 19(7):941-55. PubMed ID: 25835638
[TBL] [Abstract][Full Text] [Related]
2. The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapy.
Hojjat-Farsangi M; Moshfegh A; Daneshmanesh AH; Khan AS; Mikaelsson E; Osterborg A; Mellstedt H
Semin Cancer Biol; 2014 Dec; 29():21-31. PubMed ID: 25068995
[TBL] [Abstract][Full Text] [Related]
3. Targeting ROR1 identifies new treatment strategies in hematological cancers.
Karvonen H; Niininen W; Murumägi A; Ungureanu D
Biochem Soc Trans; 2017 Apr; 45(2):457-464. PubMed ID: 28408486
[TBL] [Abstract][Full Text] [Related]
4. Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues.
Balakrishnan A; Goodpaster T; Randolph-Habecker J; Hoffstrom BG; Jalikis FG; Koch LK; Berger C; Kosasih PL; Rajan A; Sommermeyer D; Porter PL; Riddell SR
Clin Cancer Res; 2017 Jun; 23(12):3061-3071. PubMed ID: 27852699
[No Abstract] [Full Text] [Related]
5. Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies.
Dave H; Anver MR; Butcher DO; Brown P; Khan J; Wayne AS; Baskar S; Rader C
PLoS One; 2012; 7(12):e52655. PubMed ID: 23285131
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.
Zhang S; Cui B; Lai H; Liu G; Ghia EM; Widhopf GF; Zhang Z; Wu CC; Chen L; Wu R; Schwab R; Carson DA; Kipps TJ
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17266-71. PubMed ID: 25411317
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor growth by mouse ROR1 specific antibody in a syngeneic mouse tumor model.
Hassannia H; Amiri MM; Jadidi-Niaragh F; Hosseini-Ghatar R; Khoshnoodi J; Sharifian RA; Golsaz-Shirazi F; Jeddi-Tehrani M; Shokri F
Immunol Lett; 2018 Jan; 193():35-41. PubMed ID: 29175316
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic approaches for targeting receptor tyrosine kinase like orphan receptor-1 in cancer cells.
Kamrani A; Mehdizadeh A; Ahmadi M; Aghebati-Maleki L; Yousefi M
Expert Opin Ther Targets; 2019 May; 23(5):447-456. PubMed ID: 30935250
[TBL] [Abstract][Full Text] [Related]
9. Detection of orphan receptor tyrosine kinase (ROR-1) expression in Egyptian pediatric acute lymphoblastic leukemia.
Shaheen I; Ibrahim N
Fetal Pediatr Pathol; 2012 Jun; 31(3):113-9. PubMed ID: 22369092
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the receptor tyrosine kinase ROR1 by anti-ROR1 monoclonal antibodies and siRNA induced apoptosis of melanoma cells.
Hojjat-Farsangi M; Ghaemimanesh F; Daneshmanesh AH; Bayat AA; Mahmoudian J; Jeddi-Tehrani M; Rabbani H; Mellstedt H
PLoS One; 2013; 8(4):e61167. PubMed ID: 23593420
[TBL] [Abstract][Full Text] [Related]
11. Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia.
Baskar S; Kwong KY; Hofer T; Levy JM; Kennedy MG; Lee E; Staudt LM; Wilson WH; Wiestner A; Rader C
Clin Cancer Res; 2008 Jan; 14(2):396-404. PubMed ID: 18223214
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells.
Daneshmanesh AH; Hojjat-Farsangi M; Khan AS; Jeddi-Tehrani M; Akhondi MM; Bayat AA; Ghods R; Mahmoudi AR; Hadavi R; Österborg A; Shokri F; Rabbani H; Mellstedt H
Leukemia; 2012 Jun; 26(6):1348-55. PubMed ID: 22289919
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of orphan receptor tyrosine kinase Ror1 as a putative tumor-associated antigen in Iranian patients with acute lymphoblastic leukemia.
Shabani M; Asgarian-Omran H; Jeddi-Tehrani M; Vossough P; Faranoush M; Sharifian RA; Toughe GR; Kordmahin M; Khoshnoodi J; Roohi A; Tavoosi N; Mellstedt H; Rabbani H; Shokri F
Tumour Biol; 2007; 28(6):318-26. PubMed ID: 18354269
[TBL] [Abstract][Full Text] [Related]
14. Receptor tyrosine kinase-like orphan receptor 1 (ROR-1): An emerging target for diagnosis and therapy of chronic lymphocytic leukemia.
Aghebati-Maleki L; Shabani M; Baradaran B; Motallebnezhad M; Majidi J; Yousefi M
Biomed Pharmacother; 2017 Apr; 88():814-822. PubMed ID: 28160756
[TBL] [Abstract][Full Text] [Related]
15. Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies.
Daneshmanesh AH; Porwit A; Hojjat-Farsangi M; Jeddi-Tehrani M; Tamm KP; Grandér D; Lehmann S; Norin S; Shokri F; Rabbani H; Mellstedt H; Österborg A
Leuk Lymphoma; 2013 Apr; 54(4):843-50. PubMed ID: 22988987
[TBL] [Abstract][Full Text] [Related]
16. ROR1, an embryonic protein with an emerging role in cancer biology.
Borcherding N; Kusner D; Liu GH; Zhang W
Protein Cell; 2014 Jul; 5(7):496-502. PubMed ID: 24752542
[TBL] [Abstract][Full Text] [Related]
17. Ror1 is a pseudokinase that is crucial for Met-driven tumorigenesis.
Gentile A; Lazzari L; Benvenuti S; Trusolino L; Comoglio PM
Cancer Res; 2011 Apr; 71(8):3132-41. PubMed ID: 21487037
[TBL] [Abstract][Full Text] [Related]
18. Atomic force microscopy study of the antigen-antibody binding force on patient cancer cells based on ROR1 fluorescence recognition.
Li M; Xiao X; Liu L; Xi N; Wang Y; Dong Z; Zhang W
J Mol Recognit; 2013 Sep; 26(9):432-8. PubMed ID: 23836471
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of anti ROR1 single chain fragment variable antibodies using phage display technique.
Aghebati-Maleki L; Younesi V; Jadidi-Niaragh F; Baradaran B; Majidi J; Yousefi M
Hum Antibodies; 2017; 25(1-2):57-63. PubMed ID: 28128766
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Receptor Tyrosine Kinase ROR1 by Small Molecules.
Hojjat-Farsangi M; Moshfegh A; Schultz J; Norin M; Olin T; Österborg A; Mellstedt H
Handb Exp Pharmacol; 2021; 269():75-99. PubMed ID: 34490515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]